Search the Newsreel

Apogee Enterprises: Decent Financials, But Weak Momentum Make It A Hold (NASDAQ:APOG)

Apogee Enterprises (APOG) has been rated a 'Hold' due to weak price momentum, average financials, and underwhelming dividend growth, despite trading at an approximate 18% discount to its estimated fair value. While the company reported a double beat in Q1 2027 results and the …

Fifth Third Bancorp Takes $5.37 Million Position in Apogee Therapeutics Inc. $APGE

Apogee Therapeutics (APGE) Proxy filing Summary

This article summarizes the proxy filing for Apogee Therapeutics (APGE), detailing the upcoming annual meeting on June 9, 2026. Key agenda items include the election of three Class III directors, ratification of Ernst & Young LLP as the independent auditor, and an advisory vote …

Form 4 Apogee Therapeutics Inc For: 16 July By Investing.com

This Investing.com article reports on a Form 4 filing for Apogee Therapeutics Inc. dated July 16. It includes stock market data for various indices, commodities, bonds, and individual shares, alongside popular articles and market movers. The article is brief, primarily serving as a notification …

Apogee Therapeutics (APGE) CMO donates 8,000 shares to donor advised fund

Apogee Therapeutics' Chief Medical Officer, Carl Dambkowski, reported a gift of 8,000 shares of common stock on July 14, 2026. The shares were transferred to a donor advised fund as a non-market disposition at $0.00 per share. Following this transaction, Dambkowski directly holds 169,873 …

Why (APOG) Price Action Is Critical for Tactical Trading

Apogee Enterprises Inc. (APOG) shows divergent sentiment and choppy conditions, according to AI models. The analysis provides specific trading strategies, including long, breakout, and short setups, with defined entry zones, targets, and stop losses. Multi-timeframe signal analysis also highlights support and resistance levels for …

APGE Forecast — Price Target — Prediction for 2027

Apogee Therapeutics (APGE) surges 46.7% in active-mover trading

The biotechnology stock’s move puts fresh focus on a recent weekly advance that had already been building before the latest screen spike.

Stocks making the biggest moves midday: Alphabet, AeroVironment, Salesforce, Apogee Therapeutics & more

APGE Q1 2026 Earnings: Narrower-Than-Expected Loss Fuels Modest Stock Gains - Cash Flow Report

Hear Apogee Therapeutics' June fireside talks at Jefferies and Goldman

APGE Q1 2026 Earnings: Smaller-than-Expected Loss Drives Positive Surprise - Free Cash Flow Trends

Apogee biotech with $902.9M cash eyes possible 2029 atopic dermatitis drug

Apogee Therapeutics, Inc. (APGE) stock price, news, quote and history